Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BGene Genetics specializes in developing genetically engineered bacteria or yeast to produce high-value molecules using proprietary synthetic biology technologies. The company offers both custom development services for clients across pharma, cosmetics, agri-foods and chemicals as well as its own proprietary strains. Its core innovation lies in a scar-free genetic modification process that it aims to automate at scale using big data and machine learning. The business model includes service fees or co-development with royalties.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BGene Genetics.